Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif containing 60 pseudogene 18 (TRIM60P18) is a noncoding pseudogene in the human genome, related by sequence to the tripartite motif family gene TRIM60. Like other pseudogenes, it is considered a degenerate copy that does not encode a functional protein; its regulatory or clinical relevance is not established, and it is not a therapeutic target. Pseudogenes can sometimes influence the expression of related coding genes via noncoding RNA mechanisms, but there is no evidence that TRIM60P18 has such a function[1][2][3]. Pseudogenes are generally nonfunctional DNA segments which resemble coding genes but have lost their protein-coding ability due to mutations, loss of regulatory sequences, or aberrant transcription[2][3]. Some pseudogenes are transcribed and have regulatory effects on gene expression, predominantly through RNA-based mechanisms such as acting as competing endogenous RNAs (ceRNAs) or microRNA sponges[2][3]. Not all pseudogenes have demonstrated biological or clinical impact; TRIM60P18 specifically has none recorded[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif containing 60 pseudogene 18 (TRIM60P18).